Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 53

Q-State Biosciences and 2bPrecise Announce Partnership

Posted by fidest press agency su venerdì, 16 agosto 2019

Q-State Biosciences and 2bPrecise will partner to build robust clinical-genomic datasets enabling healthcare providers to better leverage precision medicine when treating patients with genetic conditions. The collaboration will facilitate the advance of novel insights that health systems can incorporate to improve clinical practice and that pharmaceutical companies can use in the development of new therapies.
The partnership – backed by 2bPrecise parent company Allscripts Healthcare Solutions (Nasdaq:MDRX) – will combine 2bPrecise’s cloud-based, EHR-independent platform that brings genomic data into the clinical workflow with Q-State’s whole-genome and whole-exome sequencing, transcriptomics and leading functional phenotyping capabilities. The collaboration will benefit patients and care organizations by supporting improved diagnostic yields and patient outcomes, and by providing clinical tools to help match patients with precise therapies based on their health attributes and genetic profile. Likewise, it will help pharmaceutical firms accelerate therapeutic discovery through the identification of novel disease targets, stratification of patient populations and expedited clinical-trial recruitment paths.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: